Breaking News

Is Brazil Producing Enough API's?

April 2, 2014

According to research underway at Brazil's Oswaldo Cruz Foundation, Brazil has a $2.4-billion deficit in API production

According to a report published in Brazil Pharma News, and recently cited by thepharmaletter, Brazil is failing to produce the number of APIs required to produce the drugs it needs. The nation is the sixth largest pharma market in the world, according to IMS Health, but currently makes only about 1% of its APIs.  Brazil's Oswaldo Cruz Foundation has been researching this issue for some time, and recently mapped Brazilian pharma's manufacturing, technical and investmentcapacity in this area. The research aims to help create a more effective industrial policy for the pharmaceuticals sector.  

Related Contract Manufacturing:

blog comments powered by Disqus
  • Quality Risk Management

    Quality Risk Management

    Cheryl Abernathy and Bryan Sasbon, Quality Assurance Operations Manager, Ropack Pharma Solutions; QA Director & Regulatory Affairs, Ropack Pharma Solutions||September 8, 2016
    Embracing the process as a means to a strong quality culture

  • Staying Ahead in the Small Molecule Space

    Staying Ahead in the Small Molecule Space

    Dr. Matthew Moorcroft, VP Global Marketing, Cambrex||September 8, 2016
    Understand what is happening in the market and react accordingly

  • FDA & Drug Development

    FDA & Drug Development

    Rachelle Du2019Souza, Regulatory Heights Inc.||September 8, 2016
    You must perform the necessary due diligence to stay on top of regulatory developments